| Literature DB >> 30717739 |
Zhenyu Tong1, Xiaomei Zheng2,3, Yi Tong4, Yong-Cheng Shi1, Jibin Sun5,6.
Abstract
Citric acid is the world's largest consumed organic acid and is widely used in beverage, food and pharmaceutical industries. Aspergillus niger is the main industrial workhorse for citric acid production. Since the release of the genome sequence, extensive multi-omic data are being rapidly obtained, which greatly boost our understanding of the citric acid accumulation mechanism in A. niger to a molecular and system level. Most recently, the rapid development of CRISPR/Cas9 system facilitates highly efficient genome-scale genetic perturbation in A. niger. In this review, we summarize the impact of systems biology on the citric acid molecular regulatory mechanisms, the advances in metabolic engineering strategies for enhancing citric acid production and discuss the development and application of CRISPR/Cas9 systems for genome editing in A. niger. We believe that future systems metabolic engineering efforts will redesign and engineer A. niger as a highly optimized cell factory for industrial citric acid production.Entities:
Keywords: Aspergillus niger; CRISPR/Cas9 genome editing; Citric acid; Metabolic engineering; Systems biology
Mesh:
Substances:
Year: 2019 PMID: 30717739 PMCID: PMC6362574 DOI: 10.1186/s12934-019-1064-6
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Fig. 1Metabolic engineering strategies for enhancing citric acid production. The central metabolism pathway of A. niger was streamlined for citric acid production through engineering of targets for carbon utilization improvement, biosynthesis and precursor enhancement, by-product removal and feedback inhibition reduction and respiratory chain improvement. The Red Crosse represented corresponding gene (green) is deleted. The genes in red represented the targets required to be enhanced. The red dashed line with vertical bar represented the feed-back inhibition, i.e. T6P inhibited the activity of Hxk. STA starch, SUCR sucrose, GLC glucose, GLA gluconic acid, FRU fructose, G6P glucose-6-phosphate, T6P trehalose-6-phosphate, F6P fructose-6-phosphate, F-1,6-BP fructose-1,6-bisphosphate, PEP phosphoenol-pyruvate, PYR pyruvate, OAA oxaloacetate, AcCOA acetyl-CoA; MAL malate, OA oxalic acid, CIT citric acid, ICIT isocitric acid, 2-OG 2-oxoglutarate, SucCOA succinic CoA, SUCC succinate, FUM fumarate, AmyA amylase, GlaA glucoamylase, Inv inverase, AgdA alpha-1,4-glucosidase, GoxC glucose oxidase, Hxk hexokinase, GgsA trehalose-6-P synthase, Pfk1 phosphofructokinase, Pki pyruvate kinase, Pyc pyruvate decarboxylase, OahA oxaloacetate acetylhydrolase, Mdh malate dehydrogenase, Fum fumarase, Frds fumarate reductase, CitA citrate synthase, AOX1 alternative mitochondrial oxidoreductase
Metabolic engineering strategies for enhancing citric acid production in A. niger
| Strain | Engineering strategy | Original strain | Titer (g/L) | Productivity (g/L/h) | Yield (g/g sugar consumed) | By-product | Fermentation condition | References |
|---|---|---|---|---|---|---|---|---|
| Engineering carbon utilization | ||||||||
| TNA 101ΔagdA | Δ | CGMCC10142 | 172.7, ↑8.68% | 2.40 | 0.96a | ↓52.95% (residual sugar) | Liquefied corn medium, 180 g/L total sugar, 72 h | [ |
| OG1 | Δ | CGMCC10142 | 185.7, ↑16.87% | 2.58 | 1.03a | ↓88.24% (residual sugar) | Liquefied corn medium, 180 g/L total sugar, 72 h | [ |
| Enhancing citric acid biosynthesis pathway | ||||||||
| 50-2-12 | ↑ | NW129/NW131 | 55, no change | 0.33 | 0.64b | – | Synthetic medium, 140 g/L glucose, 168 h | [ |
| 55-14 | ↑ | NW129/NW131 | 46, ↓16.36% | 0.27 | 0.52b | – | Synthetic medium, 140 g/L glucose, 168 h | [ |
| Enhancing precursor supplement pathway | ||||||||
| | ↑ | ATCC1015 | 42, ↑32% | 0.35 | 0.42a | – | Synthetic medium, 100 g/L glucose, 120 h | [ |
| Δacl | Δ | AB4.1 | increased | – | 0.043b | Succinate, Oxalate, Glycerol | – | [ |
| Frds (V)-FumRs | ↑ | N402 | 29.5, ↑59.46% | 0.10 | 0.46b | Oxalate | Synthetic medium, 50 g/L glucose, 14 days | [ |
| Removal of by-product formation | ||||||||
| NW185 | Δ | NW131 | 90, ↑63.64% | 0.375 | 0.64a | No oxalate | Synthetic medium, 140 g/L glucose, 240 h | [ |
| Reducing feedback inhibition | ||||||||
| Δ1–3 | Δ | ATCC11414 | 115, ↓4.17% | – | 0.82a | – | Shu and Johnson medium, 140 g/L sucrose | [ |
| TE23 | ↑ | A158 | ~120, ↑ ~ 85% | 0.4 | 0.80a | – | Synthetic medium, 150 g/L sucrose, ~ 300 h | [ |
| Engineering Mn2+ response and morphology | ||||||||
| Brsa-25-3 | ↓ | ATCC11414 | 2.5, ↑ ~ 35% | 0.042 | – | – | Synthetic medium, 140 g/L glucose, 60 h in tested tube | [ |
| chsC-3 | ↓ | CBS513.88 | 180.3, ↑3.56% | 2.50 | 1.02a | – | Liquefied corn medium, 177 g/L total sugar, 72 h | [ |
| Regulating the respiratory chain | ||||||||
| CGMCC5751 | Adding 0.2 mg/L antimycin A | CGMCC5751 | 151.67, ↑19.89% | 2.11 | 0.82a | – | Liquefied corn medium, 184 g/L total sugar, 72 h | [ |
| CGMCC5751 | Adding 0.1 mg/L DNP | CGMCC5751 | 135.78, ↑7.32% | 1.89 | 0.74a | – | Liquefied corn medium, 184 g/L total sugar, 72 h | [ |
| CGMCC10142-72 | ↑ | CGMCC10142 | 163.1, ↑2.52% | 2.27 | 0.89a | – | Liquefied corn medium, 184 g/L total sugar, with 0.2 μg/mL antimycin A, 72 h | [ |
| CGMCC10142-102 | ↑ | CGMCC10142 | 169.1, ↑6.29% | 2.35 | 0.92a | – | Liquefied corn medium, 184 g/L total sugar, with 0.2 μg/mL antimycin A, 72 h | [ |
| CGMCC10142-3-4 | Δ | CGMCC10142 | 140.1, ↓11.95% | 1.95 | 0.76a | – | Liquefied corn medium, 184 g/L total sugar, with 0.2 μg/mL antimycin A, 72 h | [ |
| CGMCC10142-4-10 | Δ | CGMCC10142 | 125.6, ↓20.75% | 1.74 | 0.68a | – | Liquefied corn medium, 184 g/L total sugar, with 0.2 μg/mL antimycin A, 72 h | [ |
aYield g/g sugar supplied
bYield g/g sugar reported in the literatures
Fig. 2CRISPR/Cas9 genome editing systems used in A. niger. a CRISPR/Cas9 system based on RNA polymerase II promoters for sgRNA expression enables the NHEJ-mediated gene disruption in A. niger [84]. b CRISPR/Cas9 system utilizing in vitro transcription for sgRNA synthesis enables the HR-mediated gene deletion with 1.5 kb homologous arm as donor DNA [85, 86]. c CRISPR/Cas9 systems based on RNA polymerase III promoters (U6 and 5S rRNA promoters) for sgRNA expression facilitate the NHEJ-mediated gene disruption and HR-mediated gene insertion and deletion with 40 bp micro-homologous arms as donor DNA [88, 89]
CRISPR/Cas9 genome editing systems used in A. niger
| sgRNA expression | Gene editing | Donor DNA (SM/Homology arm size, bp) | Efficiency | Advantages | Limitation | References | |
|---|---|---|---|---|---|---|---|
| Promoter | Terminator | ||||||
| P | T | NHEJ-mediated gene disruption | – | Some | Less PAM limitation | Requiring to add HH and HDV, more cloning effort | [ |
| In vitro synthesis | HR-mediated gene deletion | 28–100% | Instantaneous genome editing | Hard to be used in gene regulation, dependent on sgRNA uptake and stability | [ | ||
| P | T | NHEJ-mediated gene disruption | – | Some | Less PAM limitation | Requiring to add HH and HDV, more cloning effort | [ |
| HR-mediated gene integration | 100% | ||||||
| P | Ploy (T)6 | NHEJ-mediated gene disruption | – | 15% | Less cloning effort | PAM motif (GN19GG) | [ |
| P | – | 20% | |||||
| P | – | 23% | |||||
| P | HR-mediated gene integration | 36% | |||||
| 5S rRNA | Ploy (T)6 | NHEJ-mediated gene disruption | – | 95.28–100% | High efficiency, less cloning, less PAM limitation | – | [ |
| HR-mediated gene integration and deletion | 100% | ||||||
| Multiplex gene editing | 45.83% | ||||||
Fig. 3Systemic metabolic engineering of A. niger cell factory for citric acid production. A Learn-Design-Build-Test (LDBT) cycle combines multi-omics analysis, computational biology approaches, molecular genetic manipulation toolbox and high through-put platform to achieve customized metabolic engineering on a globe scale of A. niger. With the availability of massive multi-omics data of the industrial strains, including genome, transcriptome, proteome and metabolome, genome-scale metabolic modeling could integrate these data (Learn), quantitatively describe the phenotype, and predict the potential targets for metabolic engineering (Design). These targets would be fast verified and combined using the highly efficient genome editing system, and ultimately, obtaining a new generation of cell factories for citric acid production (Build). After detection using high throughput platform and optimization of fermentation processes, the new cell factories have the potential to be industrialized (Test)